NeuImmune
Business Services · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1500 Fannie Dorsey Rd, Sykesville, Maryl...Phone Number
(301) 861-0009Website
www.neuimmune.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About NeuImmune
NeuImmune, Inc. is an early-stage biotechnology company specializing in glyco- and cell-engineering, founded by leading scientists from prestigious universities. The company aims to become a leader in glycoprotein therapeutics, focusing on enzyme replacement therapies for orphan diseases, particularly lysosomal storage disorders. NeuImmune has developed innovative technologies, including the geCHO BioDesign Platform and ICAM-1 Targeting Technology, to enhance the production and delivery of therapeutic proteins. Their target clients include patients with unmet medical needs in the realm of rare diseases.Explore more
Popular SearchesNeuimmune IncSIC Code 87,873NAICS Code 54,541Show moreNeuImmune Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NeuImmune your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if NeuImmune has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when NeuImmune launches new products
Click to see if NeuImmune had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at NeuImmune
Funding: Get notified immidiatlly once NeuImmune has new funding data
NeuImmune, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if NeuImmune is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on NeuImmune recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
NeuImmune is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
NeuImmune is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NeuImmune.
NeuImmune News & Media
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NeuImmune
Sign Up For FreeTo access detailed company insights
NeuImmune, Inc. is an early-stage biotechnology company specializing in glyco- and cell-engineering, founded by leading scientists from prestigious universities. The company aims to become a leader in glycoprotein therapeutics, focusing on enzyme replacement therapies for orphan diseases, particularly lysosomal storage disorders. NeuImmune has deve... Read More
